Table 8.
Target variable and parameters | Expert agreement | Summary | ||
|
|
Ratio of agreed features from at least 50% of experts, n | Average agreement, n | |
NYHAa | ||||
|
LA_d b | 0.77 c |
|
|
|
Age | 0.77 c | 1.00 (4/4) | 0.73 |
|
LA_Vol d | 0.62 c |
|
|
|
Atrial fibrillation | 0.77 c |
|
|
LVIDde | ||||
|
BSAf | 0.15 |
|
|
|
Gender | 0.85 c |
|
|
|
LVIDd | 0.65 c | 0.67 (4/6) | 0.52 |
|
QRS duration | 0.69 c |
|
|
|
LVEFg | 0.23 |
|
|
|
Mutation MYH7 | 0.54 c |
|
|
LVEF | ||||
|
QRS duration | 0.38 |
|
|
|
Presence of hypercholesterolemia | 0.54 c |
|
|
|
Syncope | 0.46 | 0.40 (2/5) | 0.49 |
|
Gene_Testing_Performed | 0.69 c |
|
|
|
NYHA | 0.38 |
|
|
LA_Vol | ||||
|
LA_Vol | 0.69 c |
|
|
|
BSA | 0.54 c | 0.75 (3/4) | 0.48 |
|
Age | 0.15 |
|
|
|
Atrial fibrillation | 0.54 c |
|
|
LVIDs | ||||
|
LA_d | 0.38 |
|
|
|
LVIDd | 0.38 |
|
|
|
LA_Vol | 0.62 c |
|
|
|
BSA | 0.85 c | 0.43 (3/7) | 0.47 |
|
Mutation MYBPC3 | 0.62 c |
|
|
|
Interventricular septum (IVS) | 0.38 |
|
|
|
Family history of HCMh | 0.08 |
|
|
LA _d | ||||
|
LA_d | 0.85 c |
|
|
|
Atrial fibrillation | 0.15 |
|
|
|
BSA | 0.08 | 0.17 (1/6) | 0.36 |
|
IVS | 0.38 |
|
|
|
Age | 0.31 |
|
|
|
LVEF | 0.38 |
|
|
aNYHA: New York Heart Association.
bLA_d: left atrial diameter.
cNames of parameters with agreement higher than 50% are italicized.
dLA_Vol: left atrial volume.
eLVIDd: left ventricular internal diameter at end diastole.
fBSA: body surface area.
gLVEF: left ventricular ejection fraction.
iHCM: hypertrophic cardiomyopathy.